Results 191 to 200 of about 22,180 (202)

Aripiprazole

Reactions Weekly, 2020
openaire   +2 more sources

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

Journal of Psychopharmacology, 2006
Gary Sachs, Raymond Sanchez, Ronald Marcus   +2 more
exaly  

Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia

Schizophrenia Research, 2014
Yangchun Du, Robert Risinger
exaly  

Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder

CNS Drugs, 2012
Chi-Un Pae, Ashwin A Patkar, Pae Chi-Un   +2 more
exaly  

Aripiprazole

Reactions Weekly, 2019
openaire   +1 more source

Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study

Schizophrenia Research, 2013
Suresh Mallikaarjun, John M Kane, Patricia Bricmont   +2 more
exaly  

Aripiprazole

Reactions Weekly, 2017
openaire   +1 more source

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

Expert Opinion on Investigational Drugs, 2003
Paul E Keck, Susan L Mcelroy
exaly  

Influence of Itraconazole Co-administration and CYP2D6 Genotype on the Pharmacokinetics of the New Antipsychotic ARIPIPRAZOLE

Drug Metabolism and Pharmacokinetics, 2005
Tsuyoshi Fukuda, Junichi Azuma
exaly  

Aripiprazole: pharmacology, efficacy, safety and tolerability

Expert Review of Neurotherapeutics, 2005
exaly